Objective: Accumulation of adipose tissue macrophages (ATMs) is observed in obesity and may participate in the development of insulin resistance and obesity-related complications. The aim of our study was to investigate the effect of long-term dietary intervention on ATM content in human adipose tissue. Design: We performed a multi-phase longitudinal study. Subjects and measurements: A total of 27 obese pre-menopausal women (age 39±2 years, body mass index 33.7±0.5 kg m -2 ) underwent a 6-month dietary intervention consisting of two periods: 4 weeks of very low-calorie diet (VLCD) followed by weight stabilization composed of 2 months of low-calorie diet and 3to 4 months of weight maintenance diet. At baseline and at the end of each dietary period, samples of subcutaneous adipose tissue (SAT) were obtained by needle biopsy and blood samples were drawn. ATMs were determined by flow cytometry using combinations of cell surface markers. Selected cytokine and chemokine plasma levels were measured using enzyme-linked immunosorbent assay. In addition, in a subgroup of 16 subjects, gene expression profiling of macrophage markers in SAT was performed using real-time PCR. Results: Dietary intervention led to a significant decrease in body weight, plasma insulin and C-reactive protein levels. After VLCD, ATM content defined by CD45 þ /14 þ /206 þ did not change, whereas it decreased at the end of the intervention. This decrease was associated with a downregulation of macrophage marker mRNA levels (CD14, CD163, CD68 and LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1)) and plasma levels of monocyte-chemoattractant protein-1 (MCP-1) and CXCL5 (chemokine (C-X-C motif) ligand 5). During the whole dietary intervention, the proportion of two ATM subpopulations distinguished by the CD16 marker was not changed. Conclusion: A 6-month weight-reducing dietary intervention, but not VLCD, promotes a decrease in the number of the whole ATM population with no change in the relative distribution of ATM subsets.
Introduction
Obesity is a major health problem of the twenty-first century, characterized by increased metabolic and cardiovascular complications. Its prevalence is reaching epidemic rate. During the past decade, systemic low-grade inflammation and increased accumulation of immune cells into adipose tissue (AT) have been associated with an excess of fat mass. [1] [2] [3] [4] [5] [6] Inflammation results in changes in the secretory pattern of AT. The excess fat mass is accompanied by elevated levels of pro-inflammatory cytokines (for example, tumor necrosis factor-a (TNFa) and interleukin-6), chemokines (for example, interleukin-8 and monocyte-chemoattractant protein-1 (MCP-1)) and acute-phase proteins (for example, serum amyloid A). 1, [7] [8] [9] The increased production of these bioactive molecules could be linked to the altered cell composition in the AT of obese subjects.
AT is a heterogeneous organ composed of mature adipocytes and stromavascular fraction (SVF), including mostly preadipocytes, endothelial cells, fibroblasts, macrophages and lymphocytes. Each cell type may contribute to cytokine secretion from AT. Much attention has been paid to adipose tissue macrophages (ATMs) that have been considered as one of the main sources of circulating pro-inflammatory molecules. [10] [11] [12] [13] Increased accumulation of ATMs surrounding dead or dying adipocytes was observed in obese patients and correlated with adiposity. 5, [14] [15] [16] Genetic manipulation in rodents revealed that diminished content of ATMs led to improved insulin sensitivity and decreased expression of inflammatory genes. 17, 18 There is growing evidence that
ATMs participate in an activation of inflammatory signaling pathways through Toll-like receptor and JNK-dependent pathways and lead to development of insulin resistance. 19, 20 Moreover, ATM-induced inflammation has been associated with other co-morbidities such as cardiovascular diseases, liver steatosis or type 2 diabetes.
14, [21] [22] [23] Macrophages represent various cell populations with marked plasticity that mirror different functions depending on the stimuli that come from tissue microenvironment. [24] [25] [26] In mouse models, it has been reported that ATMs have reparative (remodeling) function with anti-inflammatory phenotype (known as M2-alternatively activated macrophages), whereas newly recruited macrophages activated during obesity are mainly pro-inflammatory (known as M1-classically activated macrophages). 27, 28 In humans, ATMs express both M1-and M2-related markers, revealing an intermediate phenotype with inflammatory and antiinflammatory capacities. 10, 29, 30 Little is known regarding the stimuli that influence AT inflammation and phenotype of immune cells. One of the possible factors altering immune system could be variation in nutritional status. Up to date, no clinical study has investigated the effect of the dietinduced weight loss on ATMs. Therefore, the aim of our study was to investigate the effect of weight reduction induced by long-term dietary intervention on macrophage content and phenotype in subcutaneous adipose tissue (SAT) of obese women.
Materials and methods

Subjects
A total of 27 obese pre-menopausal women participated in the study. A subgroup of 16 subjects (subgroup 1; age 39 ± 2 years, body mass index 33.3 ± 0.5 kg m -2 ) was enrolled in a preliminary study aimed at establishing flow cytometry analysis in needle biopsy samples of AT. After the initial study, another subgroup of 11 subjects (subgroup 2; age 39 ± 2 years, body mass index 34.2 ± 0.9 kg m -2 ) was enrolled in an identical protocol in which flow cytometry analysis was performed again with a deeper characterization of ATMs. All subjects were drug free and did not suffer from any disease except for obesity. Their body weight had been stable for 3 months before the entry examination. A written informed consent to participate in the study was obtained from each subject before the study. The study was performed according to the Declaration of Helsinki and was approved by the ethical committee of the Third Faculty of Medicine (Charles University in Prague, Czech Republic). Because bleeding accompanied needle biopsy, we checked for blood contamination in AT samples. Cells positive for both CD44 and CD45 and with high granularity (high side scatter), the hallmark of granulocytes, were identified in the SAT biopsy samples. It is noteworthy that granulocytes represented a substantial fraction of cells (approximately 25%), but its content remained constant during dietary intervention (24.2±2.7% vs 22.9±2.6%). If blood contamination explained the changes in macrophage content, one could expect a parallel variation in macrophage and granulocyte numbers. However, we found no correlation between granulocyte number and macrophage content. In addition, the number of CD45/14/206À monocytes originating from the circulation was not changed during the dietary intervention. Hence, we could not find evidence of the influence of blood-contaminating cells on the interpretation of flow cytometry results.
Dietary intervention and clinical investigation
Quantification of macrophage markers expression by quantitative real-time PCR
In subgroup 1, approximately 0.5 g of AT was used for mRNA extraction. Total RNA extraction and reverse-transcription PCR were performed as previously described. 31 Before reverse transcription, genomic DNA was eliminated by DNase I (Invitrogen, Carlsbad, CA, USA ) Â fasting glucose (mmol l -1 ))/22.5. Serum C-reactive peptide levels were analyzed by immunoturbidimetry using ultrasensitive kit (Orion-Diagnostica, Espoo, Finland). Plasma levels of other parameters were determined using standard clinical biochemistry methods.
Statistical analyses
Statistical analysis was performed using SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA). The effect of weight loss on clinical data, gene expression and flow cytometry data was tested using nonparametric Wilcoxon test for paired observations. Comparison of baseline clinical data between the two interventional subgroups was performed using Mann-Whitney U-test for unpaired values. Correlations between clinical data and flow cytometry data was analyzed using Spearman's correlation coefficient. Data are presented as mean ± s.e.m. Differences at the level of Po0.05 were considered statistically significant.
Results
Effect of dietary intervention on anthropometric and metabolic parameters in obese women
In the entire group of subjects (n ¼ 27), obesity-related anthropometric parameters (weight, body mass index and waist circumference) decreased after VLCD and, further on, at the end of WS (Table 1) . Insulin resistance, as assessed by HOMA-IR, was lower at the end of both phases than at Human adipose tissue macrophages during diet M Kováčiková et al baseline. Plasma cholesterol, plasma triglycerides, plasma insulin as well as C-reactive protein levels were lower after VLCD and WS than at baseline. However, most clinical parameters showed main variations during VLCD. Statistical comparison using nonparametric Mann-Whitney test revealed no difference between the two subgroups of subjects (data not shown).
Monocyte/macrophage content and gene expression in SAT of obese women during a dietary weight loss program As this study was the first attempt to perform flow cytometry analysis on needle SAT biopsy samples, we performed a preliminary study in the subgroup 1. Monocyte/macrophage content in SVF was identified by CD45 (common leukocyte antigen) and CD14 (co-receptor of TLR4) markers. We found no change in the percentage of CD45 þ /14 þ cells after VLCD. However, when the baseline to WS and VLCD to WS values were compared, we observed diet-induced decrease in this cell population in SAT (Figure 1a) . To confirm flow cytometry results, we determined gene expression of macrophage markers CD14, CD68, CD163 and LYVE-1 using realtime PCR. The profile of the diet-induced response of macrophage marker mRNA levels was similar to that of macrophage content (Figure 1b) . The pattern of change in the percentage of CD45 þ /14 þ cells was similar in subgroup 2, that is, no change after VLCD and decrease after WS (Po0.05, data not shown).
Effect of dietary intervention on the phenotype of ATMs
In subgroup 2, adaptations of ATMs during dietary intervention were investigated using a wider panel of macrophage CD markers. As the combination of CD45 and CD14 markers 
Human adipose tissue macrophages during diet M Kováčiková et al
identifies not only population of tissue macrophages, but also blood monocytes, we used additional markers to specifically characterize ATMs. The triple-positive population identified by CD45, CD14 and CD206 markers (scavenger mannose receptor) corresponds to tissue macrophages. In the first phase of the dietary intervention, after VLCD, we did not observe any change in the number of CD45 þ / 14 þ /206 þ ATMs (Figure 2a) . However, at the end of the dietary intervention, after WS, the number of ATMs was decreased (by 43%). When the phenotype of ATM was specifically investigated using the discriminating marker CD16 (immunoglobulin G Fcg receptor III), the relative ATM subpopulation cell content characterized by the expression of CD45 þ /14 þ /206 þ /16 þ and CD45 þ /14 þ /206 þ /16À was not altered after VLCD, but decreased at the end of the dietary program (by 43 and 42%, respectively, Figures 2b and c) . The content of both ATM subpopulations did not differ at the beginning of diet. As the profile of changes was similar for both populations, we did not observe diet-induced changes in the ratio between the two subtypes of ATM.
Effect of dietary intervention on plasma levels of MCP-1, CXCL5 and TNF-a We further investigated plasma levels of selected chemokines and cytokine related to macrophage function, such as MCP-1, CXCL5 and TNF-a in the entire group of 27 obese women ( Table 1 ). The pattern of MCP-1 plasma level was similar to that of monocyte/macrophage content during dietary intervention, that is, no alteration after VLCD and decrease after WS. The circulating level of CXCL5 was already reduced after VLCD and remained decreased at the end of the whole protocol. TNF-a plasma levels did not show changes during the dietary intervention.
Relationship between ATM content and clinical parameters during dietary intervention
In subgroup 2 of 11 obese women, no correlations were found between basal levels of ATM content characterized as CD45 þ /14 þ /206 þ , clinical parameters and cytokine and chemokine plasma levels. The same findings were observed between the dietary intervention-induced changes of ATM content and these parameters. In addition, in the entire group of 27 obese women, no correlation was found between diet-induced alterations of the content of CD45 þ /14 þ cells and circulating levels of investigated molecules CXCL5, MCP-1 and TNF-a.
Discussion
In this study, we investigated the effect of different phases of a weight-reducing dietary intervention on ATM content and phenotype. During the first 4 weeks of VLCD, there was no change in ATM content and phenotype determined by flow cytometry analysis, in line with a lack of variation of macrophage marker mRNA levels. After WS, at the end of Human adipose tissue macrophages during diet M Kováčiková et al the 6-month dietary intervention, we observed a significant decrease in the whole ATM population and macrophage marker gene expression, with no alteration in the relative proportion of two ATM subpopulations distinguished by expression of the CD16 marker.
Limited data are available on the regulation of ATM content in humans. Previous studies revealed an increase of ATMs in SAT during obesity. 10, 24, 30 For the first time, we used flow cytometry approach to study ATMs during several phases of a dietary intervention. Multicolor flow cytometry analysis allowed quantitative assessment and phenotypic characterization of ATMs on a limited amount of AT obtained by needle biopsy, a mandatory condition for longitudinal studies. Moreover, compared with immunohistochemistry, flow cytometry analysis allows more accurate characterization (that is, immunophenotypization) of particular cell populations because of the use of a combination of specific markers and the analysis of a larger number of cells. However, the procedure presents several limitations. One is blood contamination causing infiltration of granulocytes into the sample. However, their content did not change during dietary intervention, as well as the content of CD45/ 14/206À cells that might be considered as monocytes coming from the circulation. Furthermore, we used in our immunofluorescent analysis specific marker for tissue macrophages, that is, CD206, which is not expressed on circulating monocytes 10 (also our own experience), to determine the whole population of ATMs. The regulation of ATM content in SAT was similar in two independent groups of subjects and in accordance with mRNA measurement of specific macrophage markers. The data obtained in this study are in agreement with a recently reported whole-genome transcriptomic analysis of AT gene expression during a long-term dietary intervention with similar design. 33 Indeed, in the VLCD phase, there was an increase or no change in inflammation-and macrophagerelated genes. At the end of the whole dietary program, there was a coordinated downregulation of these genes including CD14, CD68 and CD163, as shown in this study. Our results are also in agreement with the study of Cancello et al.
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, who observed reduction in macrophage recruitment in SAT of morbidly obese subjects at 3 months after bypass surgery determined by immunohistochemistry using CD68 and HAM56 marker and gene expression profiling. The current study brings new information about the dynamics of ATM content characterized by combination of more macrophage markers during dietary intervention in moderately obese subjects and, importantly, at multiple dietary time points.
We also observed diet-induced changes in the circulating levels of monocyte/macrophage chemoattractant protein MCP-1 and a recently published chemokine produced by ATM, CXCL5. 34 The alteration of MCP-1 levels mirrored the changes in the content of CD45 þ /14 þ cells, whereas CXCL5 already decreased after VLCD, as reported by Chavey et al. 34 Nevertheless, we did not find correlation between these chemokines and ATM content. The lack of relation may be explained by the fact that these molecules are secreted into the circulation by various cells in different tissues. 35, 36 Regarding the plasma levels of TNF-a, we did not find any changes in response to the weight reduction protocol. Similar conclusions were reached in several clinical studies with different lengths and types of diets recently reviewed by Klimcakova et al. 37 Moreover, Mohamed-Ali et al. 38 showed that AT is a poor contributor to circulating levels of TNF-a. The lack of correlation between ATM content and other clinical parameters may have several origins. First, the number of subjects (n ¼ 11) enrolled in our longitudinal study aimed at ATM content investigation was limited. Second, most changes in the metabolic parameters of obese subjects, that is, C-reactive protein, insulin, HOMA-IR and triglycerides, occurred during VLCD, whereas ATM content and gene expression decreased during WS. Finally, other insulin-sensitive tissues, such as liver and skeletal muscle, have probably been affected by the dietary intervention. It has indeed been shown that macrophages resident in these tissues (such as Kupffer cells in the liver) could be activated and induce worsening of insulin sensitivity in obese patients. 39, 40 It is known that the nature of macrophages is heterogeneous and their phenotype can be modified in various conditions. 26, 41, 42 It is therefore important to determine not only the total number of macrophages but also their phenotype in AT. From a wide range of macrophage polarization states, the most frequently described have been M1 as 'classically activated' releasing pro-inflammatory cytokines and M2 as 'alternatively activated' producing anti-inflammatory cytokines. 29, [43] [44] [45] However, the reliable markers for M1 and M2 characterization in human AT are still not clearly defined. Most results come from in vitro or animal experiments and only a limited number of human studies solve this problem. In our study, we characterized the phenotype of ATMs using cell surface markers CD45, CD14, CD206 and the discriminating marker CD16. The CD206 marker is sometimes reported as an anti-inflammatory marker. However, in recently published studies, 10, 30 it has been used for characterization of ATMs with mixed phenotype. Therefore, in this context it cannot be considered as an M2 marker. The CD16 marker has been used to show the existence of two major subsets of monocyte/macrophage subpopulations with distinct roles in target tissues.
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subtypes of ATMs did not change after VLCD and decreased after WS. The ratio between the two cell types was not modified after WS. These data suggest a decrease in total macrophage content rather than a change in macrophage phenotype after WS. In line, our previous study showed a downregulation of both pro-inflammatory (for example, human leukocyte antigen-D region, osteopontin) and antiinflammatory (for example, interleukin-10) genes. 33 These findings favor 'the balanced macrophage activation hypothesis' that explains macrophage activation as a complex of cyclic processes to keep balance between pro-and Human adipose tissue macrophages during diet M Kováčiková et al anti-inflammatory states in inflamed tissue. 49 In the mouse, high-fat diet induces a recruitment of ATM with M1 properties and no change in M2 macrophages. 27, 28 As the ratio of ATM subpopulations did not change after WM in our study, one can hypothesize that dietary-induced weight loss does not mirror dietary-induced weight gain or that species differences account for the discrepancy. Both assertions may prove correct. VLCD induced a substantial decrease in body weight; however, the number of ATMs was not decreased. The differences between human and mouse macrophages including ATM is well documented. 10, 29, 50 A recent study investigating human ATM phenotype by immunohistochemistry analysis reported that the M1/M2 ratio shifted in favor of M2 status 3 months after gastric surgery. 51 This study investigated class III morbidly obese subjects and used single markers to calculate numbers of M1 and M2 macrophages, whereas we studied class I obese women after a 6-month dietary intervention and used a combination of cell surface markers specific for macrophages. Human ATMs seem to have predominantly an anti-inflammatory M2-like phenotype (reparative/remodeling activity), but they also produce pro-inflammatory cytokines. 10, 30 Depending on microenvironmental stimuli, they could change their functional state. One of the possible factors could be peroxisome proliferator-activated receptor-g inducing M2 polarization of ATM activated through polyunsaturated fatty acid action or hypoxia as a signal for activation of inflammatory and endoplasmic reticulum stress-associated pathways. [52] [53] [54] In conclusion, our study provides evidence that ATM content in moderately obese women is not modified after the short-term severe calorie restriction phase of a dietary weight-reducing program but is substantially decreased after a 6-month period including WM. The ATM diminution is not accompanied by a change in macrophage phenotype. Further studies are needed to identify the determinants of ATM dynamics during weight reduction and to find other specific markers for the identification of macrophage activation.
